Breathe Well Live Well
UPI.com |
Preventive asthma drug for children getting closer, researchers say
UPI.com During that time, Dr. Fernando Martinez, a researcher at the Asthma and Airway Disease Research Center, said he has found that when children are exposed to environmental bacteria before age 6, it strengthens their immune systems and lowers their risk … |
View full post on asthma – Google News
BBC Sport |
Simon Yates: British cyclist fails drug test 'after asthma inhaler error'
BBC Sport British cyclist Simon Yates has failed an in-competition drugs test – with his team blaming an "administrative error" over an asthma inhaler. Orica-GreenEdge said they took "full responsibility for the mistake" and there was "no wrongdoing" by Yates … |
View full post on asthma – Google News
Medical Xpress |
Hormone drug could cure asthma and other fibrosis-related diseases
Medical Xpress Monash scientists tested the modified Relaxin hormone in animal models of heart failure and asthma. To their surprise they found that administering the new hormone intranasally to animals with chronic allergic airways disease (equivalent to asthma in … |
View full post on asthma – Google News
Condition: Asthma
Intervention: Drug: VR588
Sponsors: Imperial College London; Vectura Limited
Recruiting – verified February 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Lupin to co-market Novartis' asthma drug in India
Business Standard Lupin Limited and Novartis Healthcare Private Limited (NHPL) yesterday entered into a co-marketing agreement to promote Novartis's indacaterol/glycopyrronium (110 mcg/50 mcg) inhaler, a treatment for chronic obstructive pulmonary disease (COPD), … |
View full post on asthma – Google News
Telegraph.co.uk |
Glaxo in for competition after Hikma's generic asthma drug passes major milestone
Telegraph.co.uk Cheap versions of one of GlaxoSmithKline's top-selling asthma drugs could be available to patients as early as next year. Jordanian pharmaceuticals company Hikma moved one step closer to getting a generic version of Glaxo's Advair Diskus inhaler onto … Cipla's rival Hikma gets asthma drug nod in the US Vectura and Hikma's generic of Advair Diskus accepted for filing by US FDA Vectura Group PLC and Hikma shares given FDA boost |
View full post on asthma – Google News
|
5 facts to know about the new asthma drug
ModernMedicine FDA recently approved reslizumab (Cinqair, Teva Pharmaceuticals), an injectable used with other asthma medicines for the maintenance treatment of severe asthma. Cinqair is approved for patients who have a history of severe asthma attacks … |
View full post on asthma – Google News
|
BRIEF-Japan approves GlaxoSmithkline's asthma drug Nucala
Reuters March 29 Glaxosmithkline Plc. * Receives marketing authorisation for nucala (mepolizumab) in Japan. * Nucala is licensed in japan for adults and adolescents aged 12 years or older Source text for Eikon: Further company coverage: (Reporting By London … |
View full post on asthma – Google News
Lung Disease News |
Glaxo's asthma drug Nucala gets Japanese approval
MarketWatch The Japanese Ministry of Health, Labour and Welfare granted approval for the drug "as a treatment for bronchial asthma in patients with refractory asthma whose symptoms are inadequately controlled with standard treatment," Glaxo said Tuesday. FDA Approves Teva's Asthma Drug Cinqair as Add-on Treatment GSK: Nucala Receives Approval In Japan For Treatment Of Bronchial Asthma Nucala and Cinqair for the Treatment of Severe Asthma |
View full post on asthma – Google News
The Inquisitr |
FDA Gives Teva Go-Ahead on Asthma Drug
http://hamodia.com YERUSHALAYIM – The U.S. Food and Drug Administration (FDA) has announced approval of a new asthma treatment developed by the Israeli-based firm Teva, Globes reported on Sunday. CINQAIR injection for severe asthma sufferers is taken once every … FDA approves Cinqair to treat severe asthma Asthma Attacks Face Newly Approved Super Treatment 'Cinqair' Reslizumab (Cinqair) Approved to Treat Severe Asthma |
View full post on asthma – Google News